NTCP inhibitor

摘要

The present invention has an Xw1-W-Xw2-W structure (Xw1 and Xw2 are T, S, I, L, or V, or their N-alkyl amino acids, respectively) or P. A cyclic peptide having a -Xp1-Xp2-H structure (Xp1 is an arbitrary amino acid and Xp2 is an I, L, or V, or its N-alkyl amino acid) or a pharmaceutically acceptable salt thereof. To provide a Sodium Taurocholate Cotransporting Polypeptide (NTCP) inhibitor, which comprises.